Sep 30, 2026 09:00AM
Sep 28, 2026 08:01AM
Sep 15, 2026 08:03AM
Sep 11, 2026 08:01AM
Jul 7, 2026 08:03AM
Jun 30, 2026 08:01AM
May 18, 2026 06:46AM Allarity Therapeutics (ALLR) Misses Q1 EPS by 17c
Apr 21, 2026 08:02AM
Dec 3, 2025 09:15AM
Nov 14, 2025 04:23PM
Sep 25, 2025 05:22PM
Aug 18, 2025 04:50PM
Jul 28, 2025 01:59AM
Jul 7, 2025 08:01AM Allarity Therapeutics (ALLR) names Jeff Ervin as CFO
Jun 30, 2025 08:03AM
Jun 11, 2025 04:07PM
Jun 4, 2025 08:04AM
May 9, 2025 05:03PM
Apr 25, 2025 08:01AM
Mar 24, 2025 08:01AM
Mar 17, 2025 08:00AM Allarity Therapeutics (ALLR) Announces Presentation of Phase 2 Clinical Data from Ongoing Trial in Advanced Ovarian Cancer Patients
Mar 13, 2025 08:33AM
Mar 3, 2025 08:01AM
Feb 6, 2025 08:01AM
Feb 4, 2025 10:51AM
Jan 30, 2025 08:06AM
Nov 18, 2024 08:03AM
Oct 22, 2024 08:00AM Allarity Therapeutics (ALLR) to be Granted European Patent for DRP® Companion Diagnostic for Stenoparib
Oct 10, 2024 08:00AM
Sep 16, 2024 08:00AM
Sep 13, 2024 08:46AM
Sep 11, 2024 08:00AM
Aug 30, 2024 04:08PM
Jul 24, 2024 06:02AM
Jul 22, 2024 06:32AM Allarity Therapeutics (ALLR) Outlines Company’s 2024 Progress and Objectives
Jun 27, 2024 08:01AM

483,091 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All